Arkolith/Insider Trading/ALKS/Form 4

Hopkinson Craig C.

EVP R&D, Chief Medical OfficerAlkermes plc. (ALKS) · full profile →Form 4 · filed Sep 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$423K
Net Open-Market Flow
-$423K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 1, 2026Option exercise(M)5K$24.59$123K74K
Sep 1, 2026Sell(S)9K$46.99$423K65K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 1, 2026Option exercise(M)5K—$061K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001520262-26-000118) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Alkermes plc.

Build

Ask your agent about ALKS insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001520262-26-000118"
Ask your agent
Use Arkolith to summarize insider buying and selling at Alkermes plc.
over the last 90 days and cite the filings.